National Hepatitis B and C Training Program and Treatment Update 2016
Speakers
OVERVIEW
2016 National Hepatitis B and C Training Program and Treatment Update is organized by Scripps and would be held on Jan 23, 2016 at San Diego Marriott La Jolla, La Jolla, California, United States of America.
Viral hepatitis is the seventh leading cause of death in the world killing more people than traffic injuries HIV and AIDS or diabetes Every year chronic viral hepatitis of which hepatitis B and C are the most common forms kills a million people roughly 20 000 of them in the United States These deaths could be prevented Hepatitis B vaccine conveys 95 percent immunity and new therapies for hepatitis C cure the vast majority of patients A report from the National Academies of Sciences Engineering and Medicine released on April 11 2016 concluded that both hepatitis B and C could be rare diseases in the United States but there are substantial obstacles to meeting this goal Many of those obstacles have implications for public policy which has clearly not kept pace with the depth of the problem.
The Scripps National Hepatitis B & C Training Program and Treatment Update will contribute towards increasing the number of health care practitioners educated on the prevalence of chronic viral hepatitis, as well as those properly preventing, diagnosing, treating, and/or referring patients with chronic illness; therefore contributing towards prevention of new cases and improved management of already infected patients.
Educational Objectives:
After attending this live activity, participants should be able to:
• Discuss the prevalence and incidence of acute and chronic hepatitis B and hepatitis C both in the general US population and in at-risk populations.
• Review the history, epidemiology, demographics, natural history, histology, immunology and pathophysiology of the viral infection.
• Discuss state-of-the-art diagnostic and treatment guidelines for both hepatitis B and C.
• Formulate and/or implement strategies for preventing, diagnosing, treating, and/or referring patients with HBV and/or HCV.
• Evaluate the multidisciplinary team approach to care of patients with hepatitis B and C.
• Establish a local network of practitioners for information sharing, referrals, etc.
• Improve the health of patients infected with the HBV and/or HCV virus.
Viral hepatitis is the seventh leading cause of death in the world killing more people than traffic injuries HIV and AIDS or diabetes Every year chronic viral hepatitis of which hepatitis B and C are the most common forms kills a million people roughly 20 000 of them in the United States These deaths could be prevented Hepatitis B vaccine conveys 95 percent immunity and new therapies for hepatitis C cure the vast majority of patients A report from the National Academies of Sciences Engineering and Medicine released on April 11 2016 concluded that both hepatitis B and C could be rare diseases in the United States but there are substantial obstacles to meeting this goal Many of those obstacles have implications for public policy which has clearly not kept pace with the depth of the problem.
The Scripps National Hepatitis B & C Training Program and Treatment Update will contribute towards increasing the number of health care practitioners educated on the prevalence of chronic viral hepatitis, as well as those properly preventing, diagnosing, treating, and/or referring patients with chronic illness; therefore contributing towards prevention of new cases and improved management of already infected patients.
Educational Objectives:
After attending this live activity, participants should be able to:
• Discuss the prevalence and incidence of acute and chronic hepatitis B and hepatitis C both in the general US population and in at-risk populations.
• Review the history, epidemiology, demographics, natural history, histology, immunology and pathophysiology of the viral infection.
• Discuss state-of-the-art diagnostic and treatment guidelines for both hepatitis B and C.
• Formulate and/or implement strategies for preventing, diagnosing, treating, and/or referring patients with HBV and/or HCV.
• Evaluate the multidisciplinary team approach to care of patients with hepatitis B and C.
• Establish a local network of practitioners for information sharing, referrals, etc.
• Improve the health of patients infected with the HBV and/or HCV virus.
KEY DATES
23 Jul, 2016
Event Start Date
23 Jul, 2016
Event End Date
SPECIALITIES
GastroenterologyInfectious DiseaseSUGGESTED HOTELS
CONFERENCE VENUE
San Diego Marriott La JollaQuick Links